Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514338, 514359, 514365, 514367, 514372, 514373, 514374, 514412, 548153, 548181, 548207, 548235, 548260, 548412, 548414, 548453, 549 50, 549 51, 549 52, 549 58, 549 59, 549396, 549469, A61K 3138, C07D33300, C07D33352

Patent

active

055212131

ABSTRACT:
The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

REFERENCES:
Valadovska et al., CA102:39239, 1984.
Ivanov et al., CA70:3595, 1966.
Chem. Abstracts 44:2510b, 1950.
Chem. Ber. (1982), 115(12), 3719-36.
J. Chem. Soc., Perkin Trans. 1 (1972), (2), 218-21.
Chem. Abstracts 113 (22):201340m CA.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-787279

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.